Search

Displaying results 8051 - 8060 of 10000 in total
  1. Drug

    Renzapride

    go.drugbank.com/drugs/DB04917
    Investigational

    Renzapride is currently in Phase III clinical development in the United States for the treatment of constipation-predominant irritable bowel syndrome (IBS-C). … It has been suggested that renzapride is effective in the treatment of irritable bowel syndrome with alternating stool pattern. It is being developed by Alizyme of the UK.

  2. Drug

    1-benzylimidazole

    go.drugbank.com/drugs/DB04581
    Experimental

    1-benzylimidazole, an N-imidazole derivative, has been shown to have strong cardiotonic activity.

  3. Drug

    T-2000

    go.drugbank.com/drugs/DB11654
    Investigational

    T2000 has been used in trials studying the treatment of Myoclonus and Essential Tremor.

  4. Drug

    Revamilast

    go.drugbank.com/drugs/DB11838
    Investigational

    Revamilast has been used in trials studying the treatment of Asthma and Rheumatoid Arthritis.

  5. Drug

    AZD-7687

    go.drugbank.com/drugs/DB14949
    Investigational

    AZD-7687 is under investigation in clinical trial NCT01119352 (AZD7687 Multiple Ascending Dose Study).

  6. Drug

    ARCT-810

    go.drugbank.com/drugs/DB17683
    Investigational

    ARCT-810 is an mRNA replacement therapy that delivers ornithine transcarbamylase mRNA to hepatocytes.

  7. Drug

    AMT-162

    go.drugbank.com/drugs/DB17922
    Investigational

    AMT-162 is an adeno-associated virus serotype rh10 encoding artificial anti-SOD1 miRNA.

  8. Drug

    AVID-200

    go.drugbank.com/drugs/DB18454
    Investigational

    AVID-200 is an Anti-transforming growth factor beta (TGF-β) trap fusion protein.

  9. Drug

    Tildacerfont

    go.drugbank.com/drugs/DB18545
    Investigational

    Tildacerfont is a corticotropin-releasing factor receptor-1 antagonist containing an unfused thiazole ring

  10. Drug

    AKN-028

    go.drugbank.com/drugs/DB12746
    Investigational

    AKN-028 has been used in trials studying the treatment of Acute Myeloid Leukemia.